UNITE Study: Understanding New Interventions With GBM ThErapy
Public ClinicalTrials.gov record NCT03419403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3b Study for Management of Ocular Side Effects in Subjects With EGFR-amplified Glioblastoma Receiving Depatuxizumab Mafodotin (ABT-414)
Study identification
- NCT ID
- NCT03419403
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Steroid eye drops Drug
- Vasoconstrictor eye drops Drug
- Cold compress Other
- Ophthalmic steroid ointment Drug
- Depatuxizumab mafodotin Drug
- Temozolomide Drug
- Radiation Radiation
Drug · Other · Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2018
- Primary completion
- Sep 4, 2019
- Completion
- Mar 2, 2020
- Last update posted
- Apr 13, 2021
2018 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Usc /Id# 164235 | Los Angeles | California | 90033 | — |
| Moffitt Cancer Center /ID# 164234 | Tampa | Florida | 33612-9416 | — |
| Rush University Medical Center /ID# 171003 | Chicago | Illinois | 60612 | — |
| Northshore University Health System-Evanston /ID# 164221 | Evanston | Illinois | 60201 | — |
| CDH-Delnor Health System /ID# 169909 | Warrenville | Illinois | 60555 | — |
| Columbia University Medical Center /ID# 164220 | New York | New York | 10032-3729 | — |
| Levine Cancer Ins, Carolina Me /ID# 171271 | Charlotte | North Carolina | 28204 | — |
| UT Health Science Ctr-Houston /ID# 164223 | Houston | Texas | 77030 | — |
| Baylor Scott & White Medical Center- Temple /ID# 170792 | Temple | Texas | 76508-0001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03419403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2021 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03419403 live on ClinicalTrials.gov.